AbbVie updates 2026 EPS guidance after $291M IPR&D charge
Go back to AbbVie updates 2026 EPS guidance after $291M IPR&D charge| AbbVie (NYSE: ABBV) | Delayed: 259.36 +2.44 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $256.92 | 52 Week High | $68.12 | |||
| Open | $258.54 | 52 Week Low | $50.71 | |||
| Day High | $260.22 | P/E | 56.26 | |||
| Day Low | $256.77 | EPS | $4.61 | |||
| Volume | 4,195,205 | |||||

